TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from VicPlas International Ltd. ( (SG:569) ) is now available.
VicPlas International Ltd has addressed shareholder inquiries regarding its medical devices segment, Forefront, ahead of its upcoming AGM. The company highlights the ‘stickiness’ of its revenue streams, as customers rarely switch suppliers due to extensive testing and revalidation processes. Forefront’s products, primarily single-use medical devices, benefit from long-term customer contracts, typically spanning 8-10 years. The company also outlines its strategy for capital expenditure to expand production capacity and develop capabilities, ensuring machinery versatility across different projects. Pricing is contractually fixed with periodic reviews to accommodate variables like foreign exchange and raw material cost fluctuations.
The most recent analyst rating on (SG:569) stock is a Hold with a S$0.10 price target. To see the full list of analyst forecasts on VicPlas International Ltd. stock, see the SG:569 Stock Forecast page.
More about VicPlas International Ltd.
VicPlas International Ltd, incorporated in Singapore, operates in the medical devices industry through its subsidiary Forefront. The company focuses on manufacturing medical devices, with a strong emphasis on product integration and long-term customer relationships.
Average Trading Volume: 178,232
Technical Sentiment Signal: Hold
Current Market Cap: S$48.04M
For detailed information about 569 stock, go to TipRanks’ Stock Analysis page.